ABSTRACT
Objectives To investigate the risk of miscarriage associated with first trimester antidepressant use.
Design Population-based cohort study.
Setting UK Clinical Practice Research Datalink (CPRD) GOLD.
Participants 661 825 individuals who had 1 021 384 pregnancies in CPRD GOLD between 1996 and 2018.
Main outcome measures Miscarriage defined as a pregnancy loss prior to 24 weeks’ gestation.
Results Among the eligible pregnancies, 73 540 were prescribed antidepressants in trimester one (7.2%); 14.7% antidepressant prescribed pregnancies ended in miscarriage, as opposed to 12.4% of those not prescribed antidepressants. Antidepressant use during trimester one was associated with miscarriage in the unadjusted models (hazard ratio (HR) 1.21, 95% confidence interval (CI) 1.19 to 1.23), which attenuated following adjustment for covariates (aHR 1.04, 95% CI 1.02 to 1.06). These findings translated to an absolute risk adjusted for confounders of 13.1% (95% CI 13.0 to 13.2) in the unexposed compared to 13.6% (95% CI 13.3 to 13.8) in the first trimester antidepressant exposed. The propensity score matched model showed similar results (aHR 1.09, 95% CI 1.02 to 1.17, respectively). In those with depression or anxiety in the 12 months before pregnancy, our estimate didn’t change (aHR 1.04, 95% CI 1.01 to 1.08).
Conclusion First trimester antidepressant use was associated with a small yet clinically insignificant increase in risk of miscarriage, with no evidence suggesting taking antidepressants before pregnancy and into first trimester increases the risk of miscarriage. The conclusions are less clear for ‘incident’ antidepressant use in trimester one, however issues including gestational dating in early pregnancy and probable residual confounding prohibit us from interpreting this observation as causal.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by a Wellcome Trust PhD studentship 218495/Z/19/Z.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by CPRD's Independent Scientific Advisory Committee (ISAC) in 2021 [ISAC number: 21_000362].
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Authors’ Information: MRC Integrative Epidemiology Unit, Oakfield House, University of Bristol, BS8 2BN Florence Z. Martin PhD student MRC Integrative Epidemiology Unit, University of Bristol, BS8 2BN Paul Madley-Dowd senior research associate Department of Biomedicine, Aarhus University, Høegh-Guldbergs Gade 10, 8000 Aarhus, Denmark Viktor H. Ahlqvist postdoctoral fellow School of Psychology, University of Exeter, EX4 4QG Gemma C. Sharp associate professor of epidemiology School of Psychological Science, University of Bristol, BS8 1TU Kayleigh E. Easey senior lecturer Epidemiology and Biostatistics, Drexel University Dornsife School of Public Health, PA 19104 Brian K. Lee professor of epidemiology and biostatistics Centre for Women’s Health Research, William Henry Duncan Building, 6 West Derby Street, Liverpool, L7 8TX Abigail Merriel senior clinical lecturer in obstetrics Centre for Academic Mental Health, Canynge Hall, University of Bristol, BS8 2PN Dheeraj Rai professor of neurodevelopmental psychiatry Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT Harriet Forbes assistant professor
6 DATA AVAILABILITY STATEMENT
“Access to CPRD data, including UK Primary Care Data, and linked data such as Hospital Episode Statistics, is subject to protocol approval” as per CPRD’s guidelines. Authors are unable to share the data in its raw form, however all analytical code and codelists are open-source and found via the following links: https://github.com/flozoemartin/Miscarriage and https://github.com/flozoemartin/codelists.
